CoMFA/CoMSIA and Molecular Docking Studies of Novel Matrix Metalloproteinase- 2 Inhibitors Based on L-tyrosine Scaffold

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 5, 2016-06 ,pp. : 376-386

Bentham Science Publishers

Access to resources Recommend Favorite

CoMFA analysis of the human 1 -adrenoceptor binding affinity of a series of phenoxypropanolamines

By Louis S.N.   Rezmann-Vitti L.A.   Nero T.L.   Iakovidis D.   Jackman G.P.   Louis W.J.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 2, 2002-02 ,pp. : 111-125

Elsevier

Access to resources Recommend Favorite

3D QSAR Pharmacophore, CoMFA and CoMSIA Based Design and Docking Studies on Phenyl Alkyl Ketones as Inhibitors of Phosphodiesterase 4

By  

Medicinal Chemistry, Vol. 8, Iss. 5, 2012-09 ,pp. : 894-912

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR CoMFA Study on Oxindole Derivatives as Cyclin Dependent Kinase 1 (CDK1) and Cyclin Dependent Kinase 2 (CDK2) Inhibitors

By  

Medicinal Chemistry, Vol. 3, Iss. 1, 2007-01 ,pp. : 75-84

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR Studies of Novel Cytotoxic Bufadienolides via CoMFA and CoMSIA Approaches

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 3, 2017-01 ,pp. : 306-313

Bentham Science Publishers

Access to resources Recommend Favorite